Santiago González-Santiago

5PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 12, 2025
Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Cancer.

Miguel Martín, Ángel L Guerrero-Zotano, María E Pérez-López

|Jul 12, 2025
Real-World Data on Immune-Checkpoint Inhibitors in Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Study.

José Del Corral-Morales, Carlos Ayala-de Miguel, Laura Quintana-Cortés

|Jan 04, 2022
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor.

José Á García-Sáenz, Noelia Martínez-Jáñez, Ricardo Cubedo

|Sep 03, 2020
Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study).

Santiago González-Santiago, Cristina Saura, Eva Ciruelos

|Jan 01, 2020
SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).

S González-Santiago, T Ramón Y Cajal, E Aguirre

Pageof 1

Frequent Collaborators

2 joint publications

José Á García-Sáenz

1 joint publications

Yolanda Jerez

1 joint publications

Manuel Ramos

1 joint publications

Jose L Alonso-Romero